| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 26,224,000 | 27,130,000 | 26,574,000 | 26,704,000 | | Cost of Revenue | 24,759,000 | 25,787,000 | 25,272,000 | 25,436,000 | | | Gross Profit | 1,465,000 | 1,343,000 | 1,302,000 | 1,268,000 | | | Operating Expenses | | Research Development | 364,000 |
-
|
-
|
-
| | Selling General and Administrative | 603,000 | 904,000 | 921,000 | 897,000 | | Non Recurring |
-
| 493,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 498,000 | (54,000) | 381,000 | 371,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (66,000) | 17,000 | 33,000 | 21,000 | | Earnings Before Interest And Taxes | 439,000 | (37,000) | 414,000 | 392,000 | | Interest Expense | 42,000 | 33,000 | 35,000 | 34,000 | | Income Before Tax | 397,000 | (70,000) | 379,000 | 358,000 | | Income Tax Expense | 116,000 | (50,000) | 52,000 | 123,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 281,000 | (20,000) | 327,000 | 235,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 281,000 | (20,000) | 327,000 | 235,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $281,000 | ($20,000) | $327,000 | $235,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
